ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000878.1|Puromycin_1 # 1 # 435 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	BGC0000878.1|Puromycin_1 	1	435	+	Loose	800	24.6386	tet(31)	26.19	3000476	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATCGATGAGCTGCGGAGCTGCGGCATCTGGCAGCCGCGCAACGGAGTGGCGTCGGAGTGGGAGCACTATGTCGGCCGCCTGGCCGACTCCTTCGGTCTCTCGCTCGCCTTCTCGGGCGCGGCACTGAGCGATGAGCACTTCCTGGAACACCTGTGGAGCCACGGCGAGATGGCGTGCCTGGCCGGGGCGGACGTCTCCTACGCCTTCTCGCCGGACATCAGGAGCATCCCGCTCGTCGACCCCACGCCGGTCTACCCGTGGTCGATGGTGTGGCGTCGGCAGGCGGGCCATCCGCTCGTCGACCGGCTGGTCGGTCTGGCCAAGCGGTCGGCCGGAGACTGGCTGACCCACGTGCCCGGGGAGATCTGGCTGCCGGCGCCCGACCGGGCCCTGCTGCGCGGCGCGGGGGTCGACGTGGACGCCGTCCGGGGCTGA	IDELRSCGIWQPRNGVASEWEHYVGRLADSFGLSLAFSGAALSDEHFLEHLWSHGEMACLAGADVSYAFSPDIRSIPLVDPTPVYPWSMVWRRQAGHPLVDRLVGLAKRSAGDWLTHVPGEIWLPAPDRALLRGAGVDVDAVRG	MIGKLIMMNRYITIALLITFLDATGMGLIMPVLPTLLEEFSVKESIATHYGFILAIYALMQVIFAPILGQLSDKFGRKPVLILSLIGAVCDYTLLSFSSALWMLYLGRMIAGISAATGAVAASMVADHTKKAERTKWFGKLGAAFGAGLIAGPAIGGFIGQYSAHFPFIIAAILNAIALIMVIILFPKEQSRPKEIEQDQSKIHEKTTINAPLIHILKPVLLLLMLFFTVQLIGQIPASTWVLFTEYRFEWNTFNIGLSLAGLGLMHIIFQAFVAGYIASRWKNETVFILGFILDASAFLLLAFISQVWLVIPTLILLAGGGIALPALQGLISIKTADEHQGKIQGIMVSLTNITGIIGPPIFAFSFAKTVTNWDGTLWLIGAVLYSILLGLYFLYQKIRAYKQLKSQTA	35.12	gnl|BL_ORD_ID|609|hsp_num:0	640		
BGC0000878.1|Puromycin_2 # 750 # 2177 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.710	BGC0000878.1|Puromycin_2 	750	2177	+	Loose	585	26.9498	LAP-1	27.78	3004825	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic; tetracycline antibiotic; rifamycin antibiotic	antibiotic inactivation	LAP beta-lactamase	ATGACCGCAGGCGCGGTCGGTGTGCTCTTTCTCGCGCAGCTTGTGATTAGTTCCTCTTCGGCTGCGGCGGGGGAATCCGAGGTCACCCCGCCGCCGCTCTCCCAGGATCGGATAGAAAAGCATCTGACGCGGTTCGAGCGCATTGCGGACGCGCACGGCGGCGACCGTGCATCCGGCACGCAAGGATATGCGGAATCGGTCGACTACACCGAAAAGCTGCTCAAAAAAGCGGGATACTCGACGCAGCGCCAGCAATTCCCTTTCCGCTACACCAGGACGCTTGAGGAAAAGCTGGTGCTGCGGGACGGCAGCACACCCGGAGTCGTGGTCAGCGGCTACTCGCAGTCGACCCCCCGAGGCGGCCTGACAGCACGGCCGACGGCGGTCGGCGGGGACACCGAGCGGCGGCAGGGCTGCCGCGCCGGCGCGTACGACGGAGTGCCGGCTGGCGGGCGGATCGCGCTCGTCGACGCCGGGGGCTGCTCGATGGACGACAAGCAGCGGGTGGCCGCCGACGCCGGCGCGGCCGCCGTAATCGTCGCCAACACCGGCCCCGGCGAACTGCACACCTGGCTGGCCGACCCCGAGGCGGCCCGCATACCCATCGGCGGCGTCACCCAGGAGACGGGCCGCCTCCTCGCCGCCGAGGCACGGGCCGGACGCACCGTCCAGCTCACCCTGCGCTCGCTCACCGAACGCCGTACCACCGAGAACCTGATCGCCGTGAGCCCCCGCGGCAACCCCGAGCACACCGTGGTCTCCGGCGCCCACCTCGACTCCGTGCCGGAGGGGCCCGGCATCAACGACAACGGTGTCGCCGCCGCCGTACTGCTCGAAAGCGCCCTGGCGGCCGCCAAGGACCACGGCACCCGGGCCGAGGACAACCGGCTGGTGTTCGGCTTCTGGGGCGCGGAGGAGTTCGGCCTGCTCGGCTCGCAGCACTACGTCGACTCGTTGACCCAGGAGGAGCGTGAGCGCACCGGGCTGTACCTCAACCTGGAGATGATCGGCAGCCCCAACTACGGTCTCTTCACGCTGGATTCCAAGGCCACCGACCCCGTCACAGGACAGCGCCCGGCCCCCGGCTCGGACGAGATCGAGCGCGAGCTGACCGACGCGTTCGCCGCCCAGGGCCGCACCTCCCTGCCGGGACCCGCCGACGGGCGCTCCGACTACGTGGCGTTCCTGGGCGCGGGCATCCCCACCGGCGGGCTCTACGGAGGCTCGTTCGAGGCCAAGACCCCCGAGCAGGCCGCTCTGTGGGGCGGCACCGCTGGCCGGCCGTACGACCCCTGCTACCACCTGACGTGCGACAGGACGGCGCAGTACAGCCGCGAGGCGGCGACGCTGCACGGGCAGGCGTTCCAGACGGTGCTCACCCACTACTCCCGGCACCGGCTGGGAGAGGCAGCCGCCCACCATGGCTGA	MTAGAVGVLFLAQLVISSSSAAAGESEVTPPPLSQDRIEKHLTRFERIADAHGGDRASGTQGYAESVDYTEKLLKKAGYSTQRQQFPFRYTRTLEEKLVLRDGSTPGVVVSGYSQSTPRGGLTARPTAVGGDTERRQGCRAGAYDGVPAGGRIALVDAGGCSMDDKQRVAADAGAAAVIVANTGPGELHTWLADPEAARIPIGGVTQETGRLLAAEARAGRTVQLTLRSLTERRTTENLIAVSPRGNPEHTVVSGAHLDSVPEGPGINDNGVAAAVLLESALAAAKDHGTRAEDNRLVFGFWGAEEFGLLGSQHYVDSLTQEERERTGLYLNLEMIGSPNYGLFTLDSKATDPVTGQRPAPGSDEIERELTDAFAAQGRTSLPGPADGRSDYVAFLGAGIPTGGLYGGSFEAKTPEQAALWGGTAGRPYDPCYHLTCDRTAQYSREAATLHGQAFQTVLTHYSRHRLGEAAAHHG	MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRREERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELCNAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTPAAMAQTLQKLLNGSVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSRGIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW	166.67	gnl|BL_ORD_ID|2609|hsp_num:0	3620		
BGC0000878.1|Puromycin_3 # 2170 # 2628 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.721	BGC0000878.1|Puromycin_3 	2170	2628	+	Loose	2300	23.483	evgS	20.59	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCTGACGGGACCGCGCCCAAGCTGGTGGTGGGTGCGCTCATCAGCGATCCGCTCGGCCGGATCTTCGTACAGCGCCGCTCGGCCGACCGGCGCCTGTTCCCCGCATGCTGGGACGTCGTGGGCGGCGCCGTGGAGGACGGCGAGACCCACCACGAGGCACTGGCCCGGGAGATCGCCGAGGAGACCGGCTGGCGGCTGCGCCGGGTGCTGGCCCGGGTGGTGCACGAGAGCTGGACGGCGGACGGCGTACGGCACCTCGAGTCGGACTACGTCGTCGAGGTGGACGGGGACCTGTCGTCACCCACGCTCGAACGGGACAAGCACCCGGAGTTCGCGTGGGTGGGGCCGCAGGACATCTCCCTGCTCGACGAGAACGTCCGGCGCGGCGCCGGCACCTTCATCAAGGACACGGTCGCCGCCGGACACGACTGGCTCGCCGGATCCACGCGCCGCTGA	MADGTAPKLVVGALISDPLGRIFVQRRSADRRLFPACWDVVGGAVEDGETHHEALAREIAEETGWRLRRVLARVVHESWTADGVRHLESDYVVEVDGDLSSPTLERDKHPEFAWVGPQDISLLDENVRRGAGTFIKDTVAAGHDWLAGSTRR	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	12.70	gnl|BL_ORD_ID|1243|hsp_num:0	1318		
BGC0000878.1|Puromycin_4 # 2713 # 3729 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.662	BGC0000878.1|Puromycin_4 	2713	3729	+	Loose	750	25.409	tet(52)	28.12	3004587	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTCCACTTATTCACAGAAGCGTGCGCAACCGCGGCTGCGGGCCCTGATGGTCGGATTCGCAGGCCACCAGGGAAAGGAGTACTTACCGGTCGTCCGGGAGTACGCAGACATCGTCGGGGGCGTCGATGTCGCCCCTGCGGCGGGGGCGCTCGCCGATGACTGGGGATTTCCGCGGTTCACCGGGATCGGCGAGGCACTCAAGCGGGTCGACTTCGATGTCGCGATGGTCACCGTGCCGCACAGCGAACATTTCCCGCTGTGCAGAGAACTGCTGCTGCACGGCAAGCACATCGTCAAGGAAAAGCCGTTCGCCGTCACCGAGGAAGAGGCCCGGCAGCTGATAGAGCTGGCCGAAGGAGCGGACCGCAGCGTTTACACGCTCCTCCAGCGCAATTTCAACCCGGTCTTCCAGTTCGCGCGGAAGAACCTGGCCCGCATCGGCGATCCCTACTGGTTCTCGTACGACTACCACTTCAACCTGGCGCAGCCGACGAGCGGTTGGCGCGCCTCCCGCGAACAGGCCCTCGGCGGGGTGCTGCTCGACATGGGCTACCACCTCATCGACGTGCTCAGCGGAATGTTCCCCGAACCGAGCCGCGTGAACGCCGCCTTCGTCCACCACTACCAGGAGATGCGCGACCGGCACCTGGAGGACCTGGTCAGCCTGATGTGCAGCTACCCGTCGCCGACCCTGTCCGGCTCGCTGCGCATCTCCCGGCACAACCACGAGAAGTCCGAACGCCTCTGCGTCCTCGGCACCGGGGGCGCGCTGAACGTGGAACCCCAGGGCGCCACCCTGCACTCCACCGGCGGCCGCCTCCTCGAACGCTTCACCCGCCCCGGACCCAAGACCGACGCGGTCCGCGCCATGATCGCCCACTACCTCGGACACCTGGACGACCGGGACGTACGTGAGGACCACTTCCGTCGGCAACTCACCACCGTGCGCGTGATCGACGGGATCTACCGGGAGCGGTCACGGGAGCGGAACGAACTCGCCGATCGGTACAGCTGA	MSTYSQKRAQPRLRALMVGFAGHQGKEYLPVVREYADIVGGVDVAPAAGALADDWGFPRFTGIGEALKRVDFDVAMVTVPHSEHFPLCRELLLHGKHIVKEKPFAVTEEEARQLIELAEGADRSVYTLLQRNFNPVFQFARKNLARIGDPYWFSYDYHFNLAQPTSGWRASREQALGGVLLDMGYHLIDVLSGMFPEPSRVNAAFVHHYQEMRDRHLEDLVSLMCSYPSPTLSGSLRISRHNHEKSERLCVLGTGGALNVEPQGATLHSTGGRLLERFTRPGPKTDAVRAMIAHYLGHLDDRDVREDHFRRQLTTVRVIDGIYRERSRERNELADRYS	MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH	86.67	gnl|BL_ORD_ID|2756|hsp_num:0	3289		
BGC0000878.1|Puromycin_5 # 3762 # 6080 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0000878.1|Puromycin_5 	3762	6080	+	Loose	1000	27.335	msbA	34.62	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACGTTAAGCATCACTCTGACGCGCACACCGGGGGAGTATCTCGCCGCGGCCCTGGACCGCCCCGCCACCGCACCCGCCGCCGTCCCTGTGCTCGACCCCACGGGCCGCCATGTGTGGCCCCGCCGGATCGCCGCACGCCTCGGCCTGCCGCTGACCACCGCCCACGACCCGGACCGGCCCGCCGGCCCCGCGGCCGCGGCCGGTGACGCCACCCGTGACGAAGACGTCCTCCTGGGCGCCGCCCTCACCGAGCTGCGCACCGGCCGGGAGGAGCATCTCGTCGTGGCCGTCGCCCACGGCGACGACCACGCCTTCGCCCACCCGGCGGCCGTCTACGCCCTCGCCAAGCGCGCCCGGCTGCTGTCGGCGGCGAACGAGGACGACATCCACCGGACCGTACGGGACACCGCGCCCCGCTTCCTGACCCTCGTCGGACCCGCCCGGCTCCTCGACTTCGGCCTCGTCACACGGATACGGGCCCGCTTCCCCGCCCTCGACGTCGGCGTCCTGTACGCGCACAGCGCCGCCAAGCTCAGCGAGCTGGTCCTCAAGACGCTCGTCTACCCCGAGGCCCCCGCCACCGCTGACGTGCTGATCGCCCCGCTCCTCAAGGGCGACGAGCCCCTGCGCAACGGACAGCTGACCGTCTACCCGCAGGACGCCGTCGACGCCGCCACCTTCACACGGCCCGCCCCCCGGCCCGGCGTCGCCACCGCCGAACCGCGGGATCCGGCCGAACCGGCCCCGATGCACCGCCTGTTCAGCGTCATCACCCACGGCAGCGAGGACTACCTGCGGCTCACCTCGCAGGACATCCTGTGCGGCCTCACCCCCGACCCCGCCGAACAGGCCGCGGCACGGCGGGAGTCACGCACCCTGCCCGCCTGCATGCACGGCGGCGACTGCGTCTATCCCGACGCGCGGCGCTGGGACCCGGCCGGCATCCCCGCCCAGATCGTCTTCGCCAACGCCTGCCTCACCCTCAAACTCGGCACCCAGCTCTTCGGCAGCCACAACCGCTTCACCGTCGCCCAGCGCTTCCTCGACTCCTGGGCAGGCACCTACATAGCCAGCCCGCTGCTCAAGGACGGCACCCCCGGCGAGAACCTGCTCTTCCACTACCTGCTCGACGAGGGCGCCACCGTCGGCGGCGCGGTCCGCCAGGTCAACGACAGCCTGCGGCGCTGGGGCGTCGACGCACCCGAAGTGCTCGTCATCGGCGACCCGGAGGCCCGCTACGCCCCCGCCGCGGCACGGCCGGTGCCGGACGCGGTGACCTGCCAGGAGGAGCCGGGCCGCGCCGAGATCACCTTCGAGGGGAGGCTGCCCGCCTTCACCCGCGTCCCTCTCAAGGACCCCGACCTGCGCGAGGCCCACCGCGGCGGACAACTGCGCCTCGTCCCCGCCAAGCCGTTCGGCGGCAAACTGCCCCTCTACGGCACGTTCGGCGAAACCGCCGACGGAGAACCGGCCGCGCTGGTCTTCGGGTTCCAGGAACGCCGGCTCTCCGGCACCGAGACCTCGCGCACCCTCACCGCCGCCCCACGGCAGCGGACCGCGGCCGACCGCATCGTGCGCGCCGTGGAGCGCTACGAGAACCTCGCCGCCCTCGACATCAAGCTCGACAAGACCCGGTCGGTGCTCACCGACACCGCCAACAGCCTGCCCGCCGTGGCCCGCAGGACCAAGGACCACATCGCGGACCTGACCCAGTCGGAGCCGCTGCACCGCGCCACCGAGCGCATCCTTGCCAACTGCGCCCGCCTCGACCGGCACCTGCTCGACACCCTGCTGCGCCTCACCGAGACCCGCGAGTACCACTTCGTGGAGGCGTACCGGCCCACGTACGCCGTCGAAGAGGTCCGCAGCCCGTACGGCGAGTGCCGGTACTGCGGCGAGGCCACCCACCGCTACACCAGCGCCCATGTGCTGCGCCCGTGGCTGTGCCGCCTGCTGATCAGCTGCCCCGTGTGCGGCGCCACCCAGGACACCGAGGACGCCACGGTCGGCATCGCCATCGAAGGGGACGCCGTCCTCGCGCCCGACAGCACGACCTCGCTGCGGGCCCGGATCACCAACGACGGAGACCAGGAACTCGACCTGCTCCTCGGGGCCCGCATCACCCGCGGCAAACCGCACGGCTTCCGGTTCGCCCTGAGCCCGGACCGGCTGACCGTCCCCGCGGGCGGCACCGCCACCTCCCACCTGACCATCACCACCGGCCGGCCGACGTCCCTGCACGCCATGCTGCTGCGCTTCTACGCCGTCGGCCTGGGGCGCATCGACTTCGCGGGCCGCGATCTGCGGTTCCGCTGA	MTLSITLTRTPGEYLAAALDRPATAPAAVPVLDPTGRHVWPRRIAARLGLPLTTAHDPDRPAGPAAAAGDATRDEDVLLGAALTELRTGREEHLVVAVAHGDDHAFAHPAAVYALAKRARLLSAANEDDIHRTVRDTAPRFLTLVGPARLLDFGLVTRIRARFPALDVGVLYAHSAAKLSELVLKTLVYPEAPATADVLIAPLLKGDEPLRNGQLTVYPQDAVDAATFTRPAPRPGVATAEPRDPAEPAPMHRLFSVITHGSEDYLRLTSQDILCGLTPDPAEQAAARRESRTLPACMHGGDCVYPDARRWDPAGIPAQIVFANACLTLKLGTQLFGSHNRFTVAQRFLDSWAGTYIASPLLKDGTPGENLLFHYLLDEGATVGGAVRQVNDSLRRWGVDAPEVLVIGDPEARYAPAAARPVPDAVTCQEEPGRAEITFEGRLPAFTRVPLKDPDLREAHRGGQLRLVPAKPFGGKLPLYGTFGETADGEPAALVFGFQERRLSGTETSRTLTAAPRQRTAADRIVRAVERYENLAALDIKLDKTRSVLTDTANSLPAVARRTKDHIADLTQSEPLHRATERILANCARLDRHLLDTLLRLTETREYHFVEAYRPTYAVEEVRSPYGECRYCGEATHRYTSAHVLRPWLCRLLISCPVCGATQDTEDATVGIAIEGDAVLAPDSTTSLRARITNDGDQELDLLLGARITRGKPHGFRFALSPDRLTVPAGGTATSHLTITTGRPTSLHAMLLRFYAVGLGRIDFAGRDLRFR	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	132.65	gnl|BL_ORD_ID|2242|hsp_num:0	2423		
BGC0000878.1|Puromycin_6 # 6137 # 7426 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.721	BGC0000878.1|Puromycin_6 	6137	7426	+	Loose	600	26.9498	AAC(3)-Ib/AAC(6')-Ib''	26.09	3002600	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3); AAC(6')	ATGACCACCGCCGACAAGCTCGCCCTCCTCGGAGGCACCCCGGCCATCGACCGGCCGCTTCCCCACGAGATCTGGCCGCCCCGCGCGGACGAGGCCGAACTGGCCGCACTCACCGAGCAGCGCAACACCGACATCTCCATCAAGGGCAACAGCGGCCCCATCGGCCAACTGGAAGCCGAATTCCTCGCCTTCCTCGACCACGGCGTCCGCTACGCCGTCACCTTCAACTCCGGCACCAGCGCCCTGCTCGCCGCCTACTTCGCACTCGGCGTACGCGAGGGGGTCGAGGTGGCGGGGCCCGCGCTCACCTACCACGCCGCGCTCAGCCCCGTCTTCGCCCTGCGCGGCGACGTGGTCCTCGTCGACATCGACCCCGTCAGCCGCGGCCTCGACCCCAAGGCCCTGGAAGCGGCGATCACCGAGAACACCCGGGTCGTCACCGTCGTCCACCAGTGGGGGCACCCCTGCGACATGGACGCGATCCTGGGCGTCGCCGAGCGCTACGGACTGCGCGTCCTGGAGGACTGCTCCCACGCCCACGGCAGCCGCTACAAGGGAAAGCCGGTCGGCACCTTCGGCGACGCCGCGGTCTTCTCCCTCCAGGCCAACAAGGCCGTCTACGCGGGAGAGGGCGGCATCCTCGTCACCGACGACGCGCTGGTGCAGGACCGCGCCACCCTCCTCGGCCACTACCGGGACCGCTCCCGGGACTCGGTCATCGACGAGGAGCTGCGCTCGCACTGGGTGACCGGCTTCGGCCTGAAGCTGCGGATGTCGCCGTTCAACGCGATCGTCGCCCGGCACTCGCTCGCCGCCTTCCCCGCCCGCAAGGAGGCCCGGCACCGCTGTCTGCGCCACTTCGGCGAGTTGCTTCGCGAGGTGGACTACCTGGAGCCCATCACGGTCCCCGACCACGTCGACATGGGCGCCTGGTACGGCTACAAGCCCCTCTACCGGCCCGAGGCGCTGGGCGGCGTCCCGCGCTCCGTACTGATCGAGGCCCTGCGGGCCGAGGGCATGGAGGTCGGCGCGCCGTCCGGCCCCCGGCTGGCCACCCTGCCGCTGTACGCGCGGCCGGAGAACCCCCTCTTCCCCGGCACCCCCAAGCGCGCCAGCGCACCGGAGCCCGGCTCGCAAGCCGCCCATGTCGAGCAGCACGCCCTGTCCTTGCCCACCTTCACCGACTGGCCCGAGGACGTGGCGCTGATCGAGGCCTACGCCGAGGCCTTCCGCAAGATCGGACGGCACCGGGAGGCGCTGGCCGCCCACGCCGCCGAGACCTCCCGGTGA	MTTADKLALLGGTPAIDRPLPHEIWPPRADEAELAALTEQRNTDISIKGNSGPIGQLEAEFLAFLDHGVRYAVTFNSGTSALLAAYFALGVREGVEVAGPALTYHAALSPVFALRGDVVLVDIDPVSRGLDPKALEAAITENTRVVTVVHQWGHPCDMDAILGVAERYGLRVLEDCSHAHGSRYKGKPVGTFGDAAVFSLQANKAVYAGEGGILVTDDALVQDRATLLGHYRDRSRDSVIDEELRSHWVTGFGLKLRMSPFNAIVARHSLAAFPARKEARHRCLRHFGELLREVDYLEPITVPDHVDMGAWYGYKPLYRPEALGGVPRSVLIEALRAEGMEVGAPSGPRLATLPLYARPENPLFPGTPKRASAPEPGSQAAHVEQHALSLPTFTDWPEDVALIEAYAEAFRKIGRHREALAAHAAETSR	MSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQPTNEYLANLLHSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLKRVAVELGAYVIYVQADYGDDPAVALYTKLGVREDVMHFDIDPLTNSNDSVTLRLMTEHDLAMLYEWVNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGGGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	128.44	gnl|BL_ORD_ID|194|hsp_num:0	209		
BGC0000878.1|Puromycin_7 # 7483 # 8169 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000878.1|Puromycin_7 	7483	8169	+	Loose	400	34.2686	Erm(33)	26.25	3000599	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACTGTCAAGGAATCCCCCGAGGCCGCCGCCAAGGTCCTCGAGCACGTCATGACCGGGGACGACCTGCCGGACGACTTCTCCCTGCTGGGCCGCGAGTGGACCCTGCACCGCGGCGTCTTCCCCGGCACCCTGACCGCCGCCACCGAGGTCATGGCCTCGATCGTGCCCTATCCCAAGGGCGGCTCCTTCCTGGAGGTCGGCTGCGGCACCGGCGTCATCTCCGTGACCGCGGCGCTCCACGGCAGCGACGTCACGGCGCTCGACATCAACGAGAAGGCGGTGGCGAACACCCTCGCCAATGCCGAGCGGCACGGCGTCGAGGACCGGGTGCGGGTGCTGCACAGCGACCTGTACGCGGCGCTCGAACCCACCGACCGGTTCGACGCGATCTTCTGGAACGTGCCCTGGACGTACGTGGAGGACGGCTTCCCGCTCTCCAGCGACCTGCACTCCGCGGTCTTCGACCCCGGCTACCAGGGCCAGTCCCGGTTCATCTCCGGGGCCCGCGACCACCTGGCCGACGGCGGCCGGCTGCTGATCGGCACGGCCGATCTGGGAGACCGCGAGCGGATCGACGCCTTCGCCGCCGAGGCCGGGATGACCGTCGAGATGCTGCGCCGCGTACGCCGTATCGAGGTCGTCCGGGTCATGGAGTACCACCTGCTCGAACTGCGCGCCAAGTGA	MTVKESPEAAAKVLEHVMTGDDLPDDFSLLGREWTLHRGVFPGTLTAATEVMASIVPYPKGGSFLEVGCGTGVISVTAALHGSDVTALDINEKAVANTLANAERHGVEDRVRVLHSDLYAALEPTDRFDAIFWNVPWTYVEDGFPLSSDLHSAVFDPGYQGQSRFISGARDHLADGGRLLIGTADLGDRERIDAFAAEAGMTVEMLRRVRRIEVVRVMEYHLLELRAK	MNKKNIKDSQNFITSKRNIDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEIDHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYNIFGNIPYNISTDIVKRITFESQAKYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQPLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYKLFH	93.83	gnl|BL_ORD_ID|1650|hsp_num:0	1751		
BGC0000878.1|Puromycin_8 # 8253 # 9074 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.745	BGC0000878.1|Puromycin_8 	8253	9074	+	Loose	500	25.7942	OXA-60	29.55	3001808	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCACAGCAGGCCGACCTGGAACTGGCCATGCGACTCGCCGACACCGCCGACCGCATCACCACCCGCCGCTTCCAGGCGCGCGACTGCGGATACGCGAGGAAGCCCGACCGCACCCCCGTCACCGACGCGGACACCACCGTCGAGGCGGCCGTACGCGAGTCCGTGCGGGCCGCCCGGCCCGACGACGACTTCGCGGGAGAGGAGACCGGCGGCGAGGTGACCGCAGGACGCACCTGGATCGTCGACCCCATCGACGGCACCAAGAACTTCCTGCGCGGAGTGCCGGTCTGGGCCACGCTGATCGCGCTCCTGGAGGACGGCAGGCCCACCGTCGGCGTCGTCGCCGCGCCCGCCCTGCGCAGCCGCTGGTGGGCGGCGGCCGGGCACGGGGCCTGGCTGCGGCGCGGGTCCGCCGGCGCCGAACCGCTGCGGCTGCACGTCTCCGGTGTCGCCCGCCTCGAAAACGCCTATCTGTCCACCACCAACACCCGTACCTGGGACGCCTTCCACTCGCGCGCGGCGTATCTGCGACTCGCCGACGCCTGCTGGGAGGACCGCGCCTTCGGCGACTTCCTCCAGCACTGCATGGTCGCCGAGGGCACGGTCGACATCGCGGCCGAACCGGTCGTGAGCCCCTGGGACATCGCCGCCCTCCAGATCCTCGTGGAGGAGGCGGGCGGCGTCTGCACCGACCTGCTCGGCGGCTCGCCCCAGCGCGGGACGGGTGCCCTGTCCGCCAACCCGGAGCTGCACCGGCTCGCCGTGGAGGCCCTCGCCGCCCCCGCGGCCGCCACGACCGGTGCCGCCACCATCCCCTGA	MPQQADLELAMRLADTADRITTRRFQARDCGYARKPDRTPVTDADTTVEAAVRESVRAARPDDDFAGEETGGEVTAGRTWIVDPIDGTKNFLRGVPVWATLIALLEDGRPTVGVVAAPALRSRWWAAAGHGAWLRRGSAGAEPLRLHVSGVARLENAYLSTTNTRTWDAFHSRAAYLRLADACWEDRAFGDFLQHCMVAEGTVDIAAEPVVSPWDIAALQILVEEAGGVCTDLLGGSPQRGTGALSANPELHRLAVEALAAPAAATTGAATIP	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	100.74	gnl|BL_ORD_ID|38|hsp_num:0	47		
